Concord Biotech Limited - Company Profile

Q: Who are the current directors of Concord Biotech Limited?

The current directors of Concord Biotech Limited are Arvind Motilal Agarwal, Rajiv Ambrish Agarwal, Bharti Khanna, Amitabh Gajendra Thakore, Chakravarthy Sriraman Mandayam, Ravi Kapoor, Sudhir Jairam Vaid, Ankur Vaid, Jayaram Easwaran, Lalit Jiwan Sethi, Hina Ronak Patel.

It is a chemicals public limited company based in Ahmedabad, Gujarat, India, established in 1984.

1984 Ahmedabad, Gujarat, India Active

Last Updated: January 05, 2026

Access Report

About Concord Biotech Limited

Concord Biotech Limited, a active public limited company, was established on 23 November 1984 in Ahmedabad, Gujarat, India. Engaging in chemical products within the manufacturing sector, it holds CIN: L24230GJ1984PLC007440. Registered under ROC Roc Ahmedabad. it is listed. It has an authorized capital of ₹11.00 Cr and a paid-up capital of ₹10.46 Cr.

Formerly known as Servomed Pharmaceuticals Private Limited, Servomed Pharmaceuticals Limited. It upholds a compliant status. In 2023, it reported revenue of ₹888.48 Cr and a net worth of ₹1,291.98 Cr. Employing 1,516 professional, Its leadership includes Arvind Motilal Agarwal (Director), Rajiv Ambrish Agarwal (Director), Bharti Khanna (Director). Past directors included Harcharan Singh, Om Dutt Tyagi, Yasir Yusufali Rawjee. It holds ₹45.00 Cr open charges and ₹154.77 Cr settled loans. Its latest AGM occurred on 09 September 2025, with the balance sheet filed on 31 March 2025. It is based at 1482-86 Trasad Road Dholka, Ahmedabad, Gujarat, 387810.

Company Details

CIN/LLPIN
L24230GJ1984PLC007440
Registration Number
007440
Incorporation Date
23 November 1984
Authorized Capital
₹11.00 Cr
Paid-Up Capital
₹10.46 Cr
ROC Code
Roc Ahmedabad
Listing Status
Listed
Company Status
Active

Key Metrics

Authorised Capital ₹ 11.00 Cr as on 05-01-2026
Paid Up Capital ₹ 10.46 Cr as on 05-01-2026
Company Age 41 Year, 2 Months
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 45.00 Cr as on 05-01-2026
Satisfied Charges ₹ 154.77 Cr as on 05-01-2026
Revenue Growth **** 20.66% (FY 2023)
Profit Growth **** 33.35% (FY 2023)
Ebitda **** 25.62% (FY 2023)
Net Worth 16.69% (FY 2023)
Total Assets **** 15.32% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Concord Biotech Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Concord Biotech Limited?

Current Directors

Name	Designation	Appointment Date	Status
Arvind Motilal Agarwal	Director	24 May 2022	Current
Rajiv Ambrish Agarwal	Director	30 Jun 2008	Current
Bharti Khanna	Director	31 Jan 2017	Current
Amitabh Gajendra Thakore	Director	31 Jan 2017	Current
Chakravarthy Sriraman Mandayam	Director	14 Jun 2022	Current
Ravi Kapoor	Director	15 Dec 2003	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	05 Jul 2016	Past
Pramod Abcsdd	Director	21 Dec 2007	Past
Pramod Abcsdd	Director	04 Dec 2009	Past
Pramod Abcsdd	Additional Director	08 Jul 2022	Past
Pramod Abcsdd	Additional Director	30 Sep 2009	Past
Pramod Abcsdd	Director	04 Dec 2009	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Concord Biotech.

Concord Biotech Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 20.66% increase. The company also saw a substantial improvement in profitability, with a 33.35% increase in profit. The company's net worth Soared by an impressive increase of 16.69%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

20.66%

*******

Revenue from Operations

*******

19.67%

*******

Total Assets

*******

15.32%

*******

Profit or Loss

*******

33.35%

*******

Net Worth

*******

16.69%

*******

EBITDA

*******

25.62%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Concord Biotech?

In 2023, Concord Biotech had a promoter holding of 29.40% and a public holding of 70.60%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹450,000,000.00

Satisfied Charges

₹1,547,675,000.00

Charges Breakdown by Lending Institutions

Axis Bank Limited : 45.00 Cr

Latest Charge Details

Date	Lender	Amount	Status
27 Jan 2003	Axis Bank Limited	₹45.00 Cr	Open
17 Oct 2019	State Bank Of India	₹110.00 Cr	Satisfied
11 Aug 2015	Citi Bank N.A.	₹30.82 Cr	Satisfied
09 Dec 2014	Citi Bank N.A.	₹10.00 Cr	Satisfied
23 Jan 2012	Citibank N. A.	₹3.70 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Concord Biotech?

Concord Biotech has a workforce of 1516 employees as of Apr 14, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Concord Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Concord Biotech's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Concord Biotech

Recent Activity within the Organization

Annual General Meeting

Concord Biotech Limited last Annual general meeting of members was held on 09 Sep 2025 as per latest MCA records. was recorded as a recent event.
09 Sep 2025
Charges

The activity A charge registered on 17 Oct 2019 via Charge ID 100298054 with State Bank Of India was fully satisfied on 29 May 2025. was completed.
29 May 2025
Director Appointment

Hina Ronak Patel was appointed as a Company Secretary was appointed as a Company Secretary on 15 May 2025 & has been associated with this company since 8 months 19 days . was recorded as a recent event.
15 May 2025
Balance Sheet

Concord Biotech Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was recorded as a recent event.
31 Mar 2025
Charges

Progress on A charge with Axis Bank Limited of Rs. 45.00 Cr registered on 27 Jan 2003 with Charge ID 90099613 was modified on 31 Jul 2023. was documented.
31 Jul 2023
Director Appointment

Chakravarthy Sriraman Mandayam was appointed as a Director was appointed as a Director on 14 Jun 2022 & has been associated with this company since 3 years 7 months . was recorded as a recent event.
14 Jun 2022

Explore recent activity and updates - View Recent Activity